THE IMMUNOLOGY DATABASE AND ANALYSIS PORTAL (IMMPORT)

免疫学数据库和分析门户（IMMPORT）

• 批准号: 10934886
• 负责人: ATUL BUTTE
• 金额: $ 82.28万
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-30 至 2027-09-29
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10934886
• 关键词: COVID-19; Certification; Clinical Research; Data Set; Databases; Documentation; FAIR principles; Funding; Immunology; Infrastructure; Process; Readiness; United States National Institutes of Health; data access; data integration; data repository; data resource; data sharing; programs; research study; sharing platform; trustworthiness

As a NIH funded publicly accessible data sharing platform, ImmPort supports immunology research and clinical studies. ImmPort offers curated datasets and reference datasets that adhere to the FAIR Principles and is one of the few trustworthy biomedical data repositories certified by CoreTrustSeal. Within ImmPort, there are two specific datasets that are suitable for NAIRR pilots due to their high level of AI-readiness: the 10K Immunomes Project and the COVID-19 compendium. ImmPort make use of AWS though the NIH STRIDES program that can become a component of the open NAIRR program.

作为NIH资助的可公开访问的数据共享平台，import支持免疫学研究和临床研究。import提供符合FAIR原则的精选数据集和参考数据集，是少数几个经CoreTrustSeal认证的值得信赖的生物医学数据存储库之一。在import中，有两个特定的数据集适合NAIRR试点，因为它们的人工智能准备程度很高：10K免疫组项目和COVID-19纲要。通过NIH STRIDES项目使用AWS，该项目可以成为开放NAIRR项目的一个组成部分。